Barley stripe mosaic virus (BSMV) is known to have unusual strain-specific variations in the number of high molecular weight RNAs that can be resolved by gel electrophoresis. Analysis with recombinant DNA clones has revealed that all strains contain three distinct hybridizing species of RNA, which we now designate alpha, beta and y. The alpha- and beta-RNAs are about 4200 and 3650 nucleotides (NT), respectively, but the gamma-RNAs vary in size depending on the strain. The gamma-RNA of the Type strain is 3650 NT, and is difficult to resolve from beta-RNA by gel electrophoresis. However, the gamma-RNA of the North Dakota 18 (ND18) strain is 3250 NT and is clearly separated from beta-RNA. The results presented below show that the Argentina mild (AM) strain contains a mixture of gamma-RNAs of 3650, 3250, and 2900 NT. The 3650- and 3250-NT gamma-RNAs appear to be functional because AM subclones containing either 3650- or 3250-NT gamma-RNA can be isolated from plants inoculated with low concentrations of virus. The 2900-NT gamma-RNA is probably not capable of functioning as a genomic RNA because this RNA is not a component of any of the AM subclones.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0042-6822(83)90094-6 | DOI Listing |
J Assist Reprod Genet
January 2025
Ovarian Physiopathology Studies Laboratory, Institute of Experimental Biology and Medicine (IByME) - CONICET, Buenos Aires, Argentina.
Purpose: This study aimed to evaluate the long-term impact of mild COVID-19 infection and COVID-19 vaccination on ovarian function in patients undergoing assisted reproductive technology (ART). Specifically, we assessed ovarian outcomes between 9 and 18 months post-infection and investigated the effects of COVID-19 vaccines (inactivated virus and adenovirus) on reproductive parameters.
Methods: The study included two objectives: (a) examining ovarian function in post-COVID-19 patients (9-18 months post-infection) compared to a control group and (b) comparing reproductive outcomes in vaccinated versus unvaccinated patients.
JMIR Med Inform
January 2025
Fundación INTRAS, Valladolid, Spain.
Background: This review explores the potential of virtual reality (VR) and artificial intelligence (AI) to identify preclinical cognitive markers of Alzheimer disease (AD). By synthesizing recent studies, it aims to advance early diagnostic methods to detect AD before significant symptoms occur.
Objective: Research emphasizes the significance of early detection in AD during the preclinical phase, which does not involve cognitive impairment but nevertheless requires reliable biomarkers.
Knee
December 2024
Stockholm Sports Trauma Research Center, FIFA Medical Centre of Excellence, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Background: Some patients submitted to isolated ACL reconstruction may have symptomatic postoperative rotational instability. The objective of this study was to evaluate a population with mild rotatory instability after ACL reconstruction, which was submitted to an isolated extra-articular procedure.
Methods: Patients submitted to an isolated extra-articular procedure after ACL reconstruction were retrospectively evaluated.
Heliyon
January 2025
Laboratory of Brain Aging and Neurodegeneration, Fundación Instituto Leloir, IIBBA-CONICET, Av. Patricias Argentinas 435, Ciudad Autónoma de Buenos Aires, Argentina.
Inflammation and angiogenesis have been defined as potential mechanisms associated with clinical progression from a cognitively normal state to Alzheimer's disease (AD). In this observational case-control study, we aimed to determine plasma levels of cytokines as indicators of inflammation involved in cognitive decline. We measured 30 plasma proteins in 49 controls (CTL), 36 individuals with mild cognitive impairment (MCI) and 52 patients diagnosed with probable AD.
View Article and Find Full Text PDFPlants (Basel)
January 2025
Instituto de Biotecnología, Facultad de Ingeniería, Universidad Nacional de San Juan, Av. Libertador General San Martín 1109 (O), San Juan CP5400, Argentina.
, a recently described endemic species from southern Peru, belongs to the Amaryllidaceae family and is known for its diversity of alkaloids. Amaryllidoideae have been studied for their diverse biological activities, particularly for their properties in treating neurodegenerative diseases. This work examines the alkaloidal profile using GC-MS and UPLC-MS/MS of alkaloid-enriched extracts obtained from the leaves and bulbs of and their inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!